サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753130

モルキオ症候群治療薬の世界市場

Morquio Syndrome Drugs

出版日
ページ情報
英文 467 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
モルキオ症候群治療薬の世界市場
出版日: 2025年06月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 467 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

モルキオ症候群治療薬の世界市場は2030年までに300万米ドルに達する見込み

2024年に160万米ドルと推定されるモルキオ症候群治療薬の世界市場は、分析期間2024-2030年にCAGR 11.1％で成長し、2030年には300万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである酵素補充療法は、CAGR 9.3％を記録し、分析期間終了時には150万米ドルに達すると予測されます。造血幹細胞療法分野の成長率は、分析期間でCAGR 13.5％と推定されます。

米国市場は43万6,000米ドルと推定、中国はCAGR14.8％で成長予測

米国のモルキオ症候群治療薬市場は2024年に43万6,000米ドルと推定されます。世界第2位の経済大国である中国は、2024-2030年のCAGR14.8%で推移し、2030年には61万3,800米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.2%と9.7%と予測されています。欧州では、ドイツがCAGR約8.7%で成長すると予測されています。

世界のモルキオ症候群治療薬市場- 主要動向と促進要因まとめ

モルキオ症候群とは何か、なぜ標的治療が重要なのか？

ムコ多糖症IV型（MPS IV）としても知られるモルキオ症候群は、GALNSまたはGLB1酵素の欠損によって引き起こされる稀な常染色体劣性リソソーム貯蔵障害です。その結果、体内にグリコサミノグリカン（GAG）が蓄積し、重篤な骨格異常、関節機能障害、視力・聴力障害、心肺合併症を引き起こします。本疾患の進行性と多臓器への影響を考慮すると、薬物治療は酵素補充療法（ERT）と、進行を遅らせ症状を管理することを目的とした支持療法が中心となります。

モルキオ症候群は超希少疾患であるため、希少疾病用医薬品の開発において主な焦点となっています。MPS-IV-Aにおける根本的な酵素欠損に対処するための主要な治療法として、特にエロスルファーゼ・アルファを用いたERTが登場しました。ERTは既存の骨格障害を回復させるものではないが、持久力を向上させ、GAGの蓄積を減少させ、呼吸機能と心血管系機能を長期にわたって改善する可能性があります。根治的な治療法がない場合、適時の診断と一貫した治療が、運動能力の延長と生活の質の向上に不可欠です。

どのような技術革新が治療効果とアクセスを向上させているのか？

現在の技術革新の中心は、酵素補充療法の送達、生物学的利用能、および長期的効力の改善です。研究者たちは、半減期が長く、組織への浸透性を高めた改良型酵素、特に血管の制限のために従来のERTでは反応が不十分な骨格系を標的とした酵素を研究しています。骨や中枢神経系組織への酵素の浸透を高めるために、髄腔内投与法や融合タンパク技術が研究されています。

遺伝子治療は、ウイルスベクターを用いてGALNSまたはGLB1遺伝子の機能的コピーを導入することを目的とした、もう一つの活発な研究分野です。前臨床研究では、より少ない投与量で全身的な酵素発現が期待できることが示されています。さらに、基質減少療法（SRT）やシャペロン療法が、補助的あるいは代替的アプローチとして検討されています。これらの技術革新は、希少疾患の分子診断学、患者登録、臨床試験インフラの進歩によって可能となりつつあります。

治療需要を牽引している患者集団と地域は？

モルキオ症候群の大部分は小児患者であり、診断は通常2～6歳の間に行われます。早期の治療開始は、特に運動能力の維持と心肺機能の低下を遅らせるという点で、より良い転帰と関連しています。需要は北米と欧州に最も集中しており、新生児スクリーニングプログラム、遺伝子検査へのアクセス、希少疾病用医薬品の償還制度の利用が治療開始を支援しています。

ラテンアメリカ、中東、アジア太平洋の一部では、認知度や診断インフラが限られているため、過小診断が依然として課題となっています。しかし、擁護団体や国際的な協力により、これらの地域では患者の特定と治療へのアクセスが増加しています。遺伝子検査やバイオマーカーに基づく診断の利用可能性が高まることで、より多くの患者を早期段階で特定することが可能となり、治療薬や支持療法に対する長期的な需要が高まっています。

モルキオ症候群治療薬市場の成長はいくつかの要因によってもたらされる...

モルキオ症候群治療薬市場の成長は、希少ライソゾーム貯蔵病に対する認識の高まり、早期診断法の改善、酵素・遺伝子治療における技術革新の進行など、いくつかの要因によってもたらされます。市場の拡大は、希少疾病用医薬品の優遇措置、有利な規制の枠組み、国の希少疾病プログラムにおけるモルキオ療法の増加によって支えられています。バイオマーカーモニタリング、ドラッグデリバリー技術、実データ収集の進歩は、臨床転帰を改善し、患者へのリーチを拡大しています。ヘルスケアシステムが超希少疾患への早期介入と長期的な疾患管理を優先させる中、モルキオ症候群の新規かつ効果的な治療薬に対する需要は世界的に高まり続けています。

セグメント

治療法（酵素補充、造血幹細胞、遺伝子、その他の治療法）、疾患タイプ（モルキオA、モルキオB）、剤形（固形剤、液剤）、販売チャネル（病院薬局、オンライン薬局、小売薬局）

調査対象企業の例（全41件）

  • Abeona Therapeutics Inc.
  • Alexion Pharmaceuticals Inc.
  • Amgen Inc.
  • ArmaGen
  • BioMarin Pharmaceutical Inc.
  • Concert Pharmaceuticals Inc.
  • Genzyme Corporation
  • GREEN CROSS Corporation
  • JCR Pharmaceuticals Co., Ltd.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regenxbio Inc.
  • Sangamo Therapeutics
  • Sanofi
  • Shire plc
  • Takeda Pharmaceutical Company Limited
  • Ultragenyx Pharmaceutical Inc.
  • Vtesse Inc.
  • Zymenex A/S

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP35388

Global Morquio Syndrome Drugs Market to Reach US$3.0 Million by 2030

The global market for Morquio Syndrome Drugs estimated at US$1.6 Million in the year 2024, is expected to reach US$3.0 Million by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.5 Million by the end of the analysis period. Growth in the Hematopoietic Stem Cell Therapy segment is estimated at 13.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$436.0 Thousand While China is Forecast to Grow at 14.8% CAGR

The Morquio Syndrome Drugs market in the U.S. is estimated at US$436.0 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$613.8 Thousand by the year 2030 trailing a CAGR of 14.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.2% and 9.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.

Global Morquio Syndrome Drugs Market - Key Trends & Drivers Summarized

What Is Morquio Syndrome and Why Are Targeted Therapies Critical?

Morquio syndrome, also known as Mucopolysaccharidosis type IV (MPS IV), is a rare autosomal recessive lysosomal storage disorder caused by deficiencies in the GALNS or GLB1 enzymes. This results in the accumulation of glycosaminoglycans (GAGs) in the body, leading to severe skeletal abnormalities, joint dysfunction, vision and hearing impairment, and cardiopulmonary complications. Given the progressive nature and multisystem impact of the disease, drug treatment focuses on enzyme replacement therapy (ERT) and supportive care aimed at slowing progression and managing symptoms.

The ultra-rare status of Morquio syndrome has made it a key focus of orphan drug development efforts. ERT-particularly with elosulfase alfa-has emerged as the primary treatment to address the underlying enzyme deficiency in MPS IV-A. While it does not reverse existing skeletal damage, ERT improves endurance, reduces GAG accumulation, and may enhance respiratory and cardiovascular function over time. In the absence of curative options, timely diagnosis and consistent therapy are essential to prolong mobility and improve quality of life.

What Innovations Are Advancing Therapeutic Efficacy and Access?

Current innovations are centered on improving the delivery, bioavailability, and long-term efficacy of enzyme replacement therapies. Researchers are exploring modified enzymes with longer half-lives and enhanced tissue penetration-especially targeting the skeletal system, which remains poorly responsive to conventional ERT due to vascular limitations. Intrathecal administration methods and fusion protein technologies are being investigated to enhance enzyme access to bone and central nervous system tissues.

Gene therapy is another area of active research, aiming to introduce functional copies of the GALNS or GLB1 gene using viral vectors. Preclinical studies show promise in achieving systemic enzyme expression with potentially fewer dosing requirements. Additionally, substrate reduction therapy (SRT) and chaperone therapy are being explored as adjunct or alternative approaches. These innovations are being enabled by advancements in molecular diagnostics, patient registries, and clinical trial infrastructure for rare diseases.

Which Patient Populations and Geographies Are Driving Demand for Treatment?

Pediatric patients make up the majority of Morquio syndrome cases, with diagnosis typically occurring between ages two and six. Early treatment initiation is associated with better outcomes, particularly in maintaining mobility and slowing cardiopulmonary decline. Demand is most concentrated in North America and Europe, where newborn screening programs, access to genetic testing, and availability of orphan drug reimbursement frameworks support treatment initiation.

In Latin America, the Middle East, and parts of Asia-Pacific, underdiagnosis remains a challenge due to limited awareness and diagnostic infrastructure. However, advocacy groups and international collaborations are increasing patient identification and access to therapies in these regions. The increasing availability of genetic testing and biomarker-based diagnosis is helping identify more patients at earlier stages, driving long-term demand for therapies and supportive care.

The Growth in the Morquio Syndrome Drugs Market Is Driven by Several Factors…

The growth in the Morquio syndrome drugs market is driven by several factors including rising awareness of rare lysosomal storage diseases, improvements in early diagnostic methods, and ongoing innovation in enzyme and gene therapies. Market expansion is supported by orphan drug incentives, favorable regulatory frameworks, and increasing inclusion of Morquio therapies in national rare disease programs. Advances in biomarker monitoring, drug delivery technologies, and real-world data collection are improving clinical outcomes and expanding patient reach. As healthcare systems prioritize earlier intervention and long-term disease management for ultra-rare disorders, demand for novel and more effective Morquio syndrome therapies continues to rise globally.

SCOPE OF STUDY:

The report analyzes the Morquio Syndrome Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy, Other Treatments); Disease Type (Morquio A, Morquio B); Form (Solid Form, Liquid Form); Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abeona Therapeutics Inc.
  • Alexion Pharmaceuticals Inc.
  • Amgen Inc.
  • ArmaGen
  • BioMarin Pharmaceutical Inc.
  • Concert Pharmaceuticals Inc.
  • Genzyme Corporation
  • GREEN CROSS Corporation
  • JCR Pharmaceuticals Co., Ltd.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regenxbio Inc.
  • Sangamo Therapeutics
  • Sanofi
  • Shire plc
  • Takeda Pharmaceutical Company Limited
  • Ultragenyx Pharmaceutical Inc.
  • Vtesse Inc.
  • Zymenex A/S

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Morquio Syndrome Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Diagnosis Rates and Improved Genetic Screening Drive Early Identification of Morquio Syndrome
    • Expansion of Orphan Drug Designations Spurs R&D in Enzyme Replacement Therapies (ERTs)
    • OEM Focus on Long-Term Disease Management Supports Development of Targeted Therapies
    • Increased Awareness Campaigns and Advocacy Efforts Strengthen Early Intervention and Drug Uptake
    • Growing Collaboration Between Biopharma Firms and Rare Disease Foundations Enhances R&D Funding
    • Advancements in Biomarker Development Improve Monitoring of Drug Efficacy in MPS IV Patients
    • Push for Home Infusion and Outpatient Administration Models Enhances Treatment Accessibility
    • Pipeline Expansion of Novel Therapeutic Candidates Supports Long-Term Market Outlook
    • Rising Demand for Personalized Medicine Approaches Fuels Development of Genotype-Specific Treatments
    • Global Expansion of Rare Disease Registries Improves Epidemiological Data and Market Targeting
    • OEM Innovation in Chaperone and Gene Therapies Expands Therapeutic Options for Morquio Syndrome
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Morquio Syndrome Drugs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Morquio Syndrome Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Enzyme Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Enzyme Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Enzyme Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematopoietic Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematopoietic Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hematopoietic Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Morquio A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Morquio A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Morquio A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Morquio B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Morquio B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Morquio B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Solid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Solid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Solid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Liquid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • JAPAN
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • CHINA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • EUROPE
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Morquio Syndrome Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • FRANCE
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 101: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • GERMANY
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • INDIA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 212: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Morquio Syndrome Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Morquio Syndrome Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • AFRICA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030

IV. COMPETITION